{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:10Z","timestamp":1787501290148,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41390-021-01698-x","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:18:12Z","timestamp":1629195492000},"page":"206-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles"],"prefix":"10.1038","volume":"92","author":[{"given":"Melanie R. F.","family":"Gropler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Lipshultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Towbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Colan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Canter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory J.","family":"Lavine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"1698_CR1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.healun.2019.08.002","volume":"38","author":"JW Rossano","year":"2019","unstructured":"Rossano, J. W. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report - 2019; focus theme: donor and recipient size match. J. Heart Lung Transplant. 38, 1028\u20131041 (2019).","journal-title":"J. Heart Lung Transplant."},{"key":"1698_CR2","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","volume":"296","author":"JA Towbin","year":"2006","unstructured":"Towbin, J. A. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296, 1867\u20131876 (2006).","journal-title":"JAMA"},{"key":"1698_CR3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L Kober","year":"2016","unstructured":"Kober, L. et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N. Engl. J. Med. 375, 1221\u20131230 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1698_CR4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","volume":"57","author":"M Merlo","year":"2011","unstructured":"Merlo, M. et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J. Am. Coll. Cardiol. 57, 1468\u20131476 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/14779072.2016.1125292","volume":"14","author":"M Merlo","year":"2016","unstructured":"Merlo, M. et al. Clinical management of dilated cardiomyopathy: current knowledge and future perspectives. Expert Rev. Cardiovasc.Ther. 14, 137\u2013140 (2016).","journal-title":"Expert Rev. Cardiovasc.Ther."},{"key":"1698_CR6","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.jacc.2017.09.1089","volume":"70","author":"RK Singh","year":"2017","unstructured":"Singh, R. K. et al. Survival without cardiac transplantation among children with dilated cardiomyopathy. J. Am. Coll. Cardiol. 70, 2663\u20132673 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2011.10.878","volume":"59","author":"E Pahl","year":"2012","unstructured":"Pahl, E. et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J. Am. Coll. Cardiol. 59, 607\u2013615 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/CIRCULATIONAHA.113.003615","volume":"129","author":"JW Rossano","year":"2014","unstructured":"Rossano, J. W. & Shaddy, R. E. Update on pharmacological heart failure therapies in children: do adult medications work in children and if not, why not? Circulation 129, 607\u2013612 (2014).","journal-title":"Circulation"},{"key":"1698_CR9","doi-asserted-by":"publisher","unstructured":"Patel, M. D. et al. Pediatric and adult dilated cardiomyopathy represent distinct pathological entities. JCI Insight 2(14):e94382, https:\/\/doi.org\/10.1172\/jci.insight.94382 (2017).","DOI":"10.1172\/jci.insight.94382"},{"key":"1698_CR10","doi-asserted-by":"publisher","unstructured":"Tatman, P. D. et al. Pediatric dilated cardiomyopathy hearts display a unique gene expression profile. JCI Insight 2(14):e94249, https:\/\/doi.org\/10.1172\/jci.insight.94249 (2017).","DOI":"10.1172\/jci.insight.94249"},{"key":"1698_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ppedcard.2010.11.008","volume":"31","author":"E Rampersaud","year":"2011","unstructured":"Rampersaud, E. et al. Rare variant mutations identified in pediatric patients with dilated cardiomyopathy. Prog. Pediatr. Cardiol. 31, 39\u201347 (2011).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"1698_CR12","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2018.08.2171","volume":"72","author":"C Vasilescu","year":"2018","unstructured":"Vasilescu, C. et al. Genetic basis of severe childhood-onset cardiomyopathies. J. Am. Coll. Cardiol. 72, 2324\u20132338 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","volume":"24","author":"RE Hershberger","year":"2018","unstructured":"Hershberger, R. E. et al. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America Practice Guideline. J. Card. Fail. 24, 281\u2013302 (2018).","journal-title":"J. Card. Fail."},{"key":"1698_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ppedcard.2011.06.003","volume":"32","author":"PF Kantor","year":"2011","unstructured":"Kantor, P. F. et al. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: summary from the Second International Conference On Pediatric Cardiomyopathy. Prog. Pediatr. Cardiol. 32, 11\u201314 (2011).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"1698_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ppedcard.2019.02.004","volume":"53","author":"MD Everitt","year":"2019","unstructured":"Everitt, M. D. et al. Cardiac biomarkers in pediatric cardiomyopathy: study design and recruitment results from the Pediatric Cardiomyopathy Registry. Prog. Pediatr. Cardiol. 53, 1\u201310 (2019).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"1698_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11897-016-0303-y","volume":"13","author":"SR Motiwala","year":"2016","unstructured":"Motiwala, S. R. & Gaggin, H. K. Biomarkers to predict reverse remodeling and myocardial recovery in heart failure. Curr. Heart Fail. Rep. 13, 207\u2013218 (2016).","journal-title":"Curr. Heart Fail. Rep."},{"key":"1698_CR17","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2020.08.061","volume":"76","author":"L Adamo","year":"2020","unstructured":"Adamo, L. et al. Proteomic signatures of heart failure in relation to left ventricular ejection fraction. J. Am. Coll. Cardiol. 76, 1982\u20131994 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1017\/S1047951115000943","volume":"25","author":"JD Wilkinson","year":"2015","unstructured":"Wilkinson, J. D. et al. Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group. Cardiol. Young 25, 140\u2013153 (2015).","journal-title":"Cardiol. Young"},{"key":"1698_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCHEARTFAILURE.113.000359","volume":"6","author":"SM Joseph","year":"2013","unstructured":"Joseph, S. M. et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ. Heart Fail. 6, 1139\u20131146 (2013).","journal-title":"Circ. Heart Fail."},{"key":"1698_CR20","first-page":"543","volume":"29","author":"L Gold","year":"2012","unstructured":"Gold, L., Walker, J. J., Wilcox, S. K. & Williams, S. Advances in human proteomics at high scale with the SOMAscan proteomics platform. Nat. Biotechnol. 29, 543\u2013549 (2012).","journal-title":"Nat. Biotechnol."},{"key":"1698_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14755-5","volume":"7","author":"J Candia","year":"2017","unstructured":"Candia, J. et al. Assessment of variability in the SOMAscan assay. Sci. Rep. 7, 14248 (2017).","journal-title":"Sci. Rep."},{"key":"1698_CR22","first-page":"709","volume":"36","author":"S Amorim","year":"2017","unstructured":"Amorim, S. et al. The role of biomarkers in dilated cardiomyopathy: assessment of clinical severity and reverse remodeling. Portuguese J. Cardiol. 36, 709\u2013716 (2017).","journal-title":"Portuguese J. Cardiol."},{"key":"1698_CR23","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1542\/peds.110.6.e76","volume":"110","author":"TS Mir","year":"2002","unstructured":"Mir, T. S. et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110, e76 (2002).","journal-title":"Pediatrics"},{"key":"1698_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.amjcard.2010.10.015","volume":"107","author":"DT Wong","year":"2011","unstructured":"Wong, D. T. et al. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure. Am. J. Cardiol. 107, 573\u2013578 (2011).","journal-title":"Am. J. Cardiol."},{"key":"1698_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2009.06.020","volume":"54","author":"YM Law","year":"2009","unstructured":"Law, Y. M., Hoyer, A. W., Reller, M. D. & Silberbach, M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study. J. Am. Coll. Cardiol. 54, 1467\u20131475 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ahj.2009.10.022","volume":"159","author":"T Tsutamoto","year":"2010","unstructured":"Tsutamoto, T. et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am. Heart J. 159, 63\u201367 (2010).","journal-title":"Am. Heart J."},{"key":"1698_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ahj.2007.11.001","volume":"155","author":"C Ratnasamy","year":"2008","unstructured":"Ratnasamy, C., Kinnamon, D. D., Lipshultz, S. E. & Rusconi, P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am. Heart J. 155, 527\u2013533 (2008).","journal-title":"Am. Heart J."},{"key":"1698_CR28","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2016.5951","volume":"315","author":"P Ganz","year":"2016","unstructured":"Ganz, P. et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA 315, 2532\u20132541 (2016).","journal-title":"JAMA"},{"key":"1698_CR29","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","volume":"41","author":"C Heymes","year":"2003","unstructured":"Heymes, C. et al. Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41, 2164\u20132171 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1698_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1253\/circj.CJ-10-0837","volume":"75","author":"C Kawahara","year":"2011","unstructured":"Kawahara, C. et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ. J. 75, 656\u2013661 (2011).","journal-title":"Circ. J."},{"key":"1698_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","volume":"11","author":"RA de Boer","year":"2009","unstructured":"de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H. & van Veldhuisen, D. J. Galectin-3: a novel mediator of heart failure development and progression. Eur. J. Heart Fail. 11, 811\u2013817 (2009).","journal-title":"Eur. J. Heart Fail."},{"key":"1698_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/CIRCHEARTFAILURE.108.833707","volume":"2","author":"RV Shah","year":"2009","unstructured":"Shah, R. V., Chen-Tournoux, A. A., Picard, M. H., van Kimmenade, R. R. & Januzzi, J. L. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ. Heart Fail. 2, 311\u2013319 (2009).","journal-title":"Circ. Heart Fail."},{"key":"1698_CR33","doi-asserted-by":"crossref","unstructured":"Riddell, A. et al. RUNX1: an emerging therapeutic target for cardiovascular disease. Cardiovasc. Res. 116(8), 1410\u20131423 (2020).","DOI":"10.1093\/cvr\/cvaa034"},{"key":"1698_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","volume":"16","author":"F Kruiswijk","year":"2015","unstructured":"Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393\u2013405 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1698_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.117.028911","volume":"137","author":"CS McCarroll","year":"2018","unstructured":"McCarroll, C. S. et al. Runx1 deficiency protects against adverse cardiac remodeling after myocardial infarction. Circulation 137, 57\u201370 (2018).","journal-title":"Circulation"},{"key":"1698_CR36","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1073\/pnas.1621436114","volume":"114","author":"TW Mak","year":"2017","unstructured":"Mak, T. W., Hauck, L., Grothe, D. & Billia, F. p53 regulates the cardiac transcriptome. Proc. Natl Acad. Sci. USA 114, 2331\u20132336 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1698_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","volume":"124","author":"SN Chen","year":"2019","unstructured":"Chen, S. N. et al. DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A\/C) mutations. Circulation Res. 124, 856\u2013873 (2019).","journal-title":"Circulation Res."},{"key":"1698_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/atm.2017.06.27","volume":"5","author":"D Moris","year":"2017","unstructured":"Moris, D. et al. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Ann. Transl. Med. 5, 326 (2017).","journal-title":"Ann. Transl. Med."},{"key":"1698_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-018-1067-7","volume":"20","author":"SM Schumacher","year":"2018","unstructured":"Schumacher, S. M. & Naga Prasad, S. V. Tumor necrosis factor-alpha in heart failure: an updated review. Curr. Cardiol. Rep. 20, 117 (2018).","journal-title":"Curr. Cardiol. Rep."},{"key":"1698_CR40","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/ars.2012.4588","volume":"19","author":"D Zablocki","year":"2013","unstructured":"Zablocki, D. & Sadoshima, J. Angiotensin II and oxidative stress in the failing heart. Antioxid. Redox Signal. 19, 1095\u20131109 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"1698_CR41","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos, A., Rengo, G. & Koch, W. J. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ. Res. 113, 739\u2013753 (2013).","journal-title":"Circ. Res."},{"key":"1698_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00395-011-0190-z","volume":"106","author":"A Sirker","year":"2011","unstructured":"Sirker, A., Zhang, M. & Shah, A. M. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res. Cardiol. 106, 735\u2013747 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"1698_CR43","doi-asserted-by":"publisher","unstructured":"Sullivan, R. D., Mehta, R. M., Tripathi, R., Reed, G. L. & Gladysheva, I. P. Renin activity in heart failure with reduced systolic function-new insights. Int. J. Mol. Sci. 20(13):3182 https:\/\/doi.org\/10.3390\/ijms20133182 (2019).","DOI":"10.3390\/ijms20133182"},{"key":"1698_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cardfail.2015.06.381","volume":"21","author":"JL Jefferies","year":"2015","unstructured":"Jefferies, J. L. et al. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the Pediatric Cardiomyopathy Registry. J. Card. Fail. 21, 877\u2013884 (2015).","journal-title":"J. Card. Fail."},{"key":"1698_CR45","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.112.104638","volume":"126","author":"SA Webber","year":"2012","unstructured":"Webber, S. A. et al. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation 126, 1237\u20131244 (2012).","journal-title":"Circulation"},{"key":"1698_CR46","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.110.973826","volume":"124","author":"JA Alvarez","year":"2011","unstructured":"Alvarez, J. A. et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation 124, 814\u2013823 (2011).","journal-title":"Circulation"},{"key":"1698_CR47","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jacc.2013.11.059","volume":"63","author":"MD Everitt","year":"2014","unstructured":"Everitt, M. D. et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J. Am. Coll. Cardiol. 63, 1405\u20131413 (2014).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01698-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01698-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T14:05:19Z","timestamp":1675605919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01698-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1698"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01698-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All adult and pediatric registry patients included had provided written informed consented previously for use of data and specimens for future research use at the time of registry enrollment. All control pediatric control subjects underwent written informed consent at the time of study enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}